2-Day Virtual Seminar Managing GMP Compliance and Phase Appropriate GMP Considerations for Virtual Companies

David L Chesney
Irvine,CA
May 10 - May 11 , 2021

Starting at

$1699

Premier price: $1614 (save 5%)

Single registration

May 10 - May 11 , 2021
Buy Now

This program combines general considerations for Good Manufacturing Practice (GMP) compliance management with the principles of phase-appropriate GMP considerations, with an emphasis on needs of virtual companies. ("Virtual companies" are those who outsource GMP operations to Contract Manufacturing Organizations (CMOs) and Contract Analytical Laboratories.)

Virtual companies typically do not conduct “hands on” manufacturing, but do perform tasks which are governed by GMP, for example, dispositioning final product, managing the supply chain, investigating complaints, and providing training to staff in GMP compliance concepts. Such companies often struggle to decide how to structure their quality management system, which procedures they need or do not need, and how to best manage vendor relationships. In addition, the application of GMP requirements to the manufacture of investigational products requires exercise of judgement over the life cycle from early phase (Phase 1) to peri-approval (late Phase 3). Understanding what is required by FDA and other regulatory agencies is important to assure timely approval, since GMP compliance issues can result in approval delays.

In this two day workshop conference you will learn how GMP applies directly to virtual company operations, how to best structure a quality management system in a virtual company, and a method to decide which procedures are necessary at what points in time. You will also learn best practices for quality agreements and vendor management. In addition, you will learn the current guidance from FDA for application of GMP to the manufacture of Phase 1, 2 and 3 clinical trial materials. Though FDA requirements are the primary emphasis, some discussion of EMA (European) requirements and other venues will also be included.

Learning Objectives:

Upon completing this course participants should:

  • Understand the fundamentals of GMP for the United States
  • Understand how to determine what GMP-governed operations you are performing internally versus what you are outsourcing
  • Understand a method to structure your quality management system and decide which procedures you need now versus which ones can wait
  • Understand best practices for vendor management
  • Learn how to apply GMP concepts to Phase 1, 2 and 3 investigational drugs
  • Learn the differences between an FDA GMP inspection, a Pre-Approval Inspection and a Pre-License Inspection and where to obtain guidance for each
  • Understand basic principles of FDA inspection authority, what to expect if FDA inspects your virtual firm, and how to manage the presence of FDA personnel on site

Who will Benefit:

This course is designed for persons responsible for GMP compliance management following a virtual model, both pre- and post-market. Though designed with small company needs in mind, the principles are also useful to those in larger companies who manage CMOs, particularly those manufacturing investigational drug API and finished products:

  • Senior quality managers
  • Quality professionals
  • Regulatory professionals
  • Compliance professionals
  • Production supervisors
  • Manufacturing engineers
  • Production engineers
  • Quality engineers
  • Quality auditors

DAY 01(11:00 AM - 5:00 PM EDT)
  • Introduction and objectives
  • Virtual Company Challenges
    • Importance of quality management to business success
  • GMP defined and the Legal basis of GMP
    • Meaning of the term “Manufacturing”
    • CMO Role
    • Role of the contracting company
    • Specific GMP requirements that apply to virtual companies
  • Structuring a Quality Management System in a Virtual Company Setting
    • Structuring the organization and the Quality Unit
    • Structuring a document control hierarchy
    • Determining what procedures to have in place
  • Supply Chain Quality Management
    • Legal basis for this requirement of GMP
    • Vendor selection considerations
    • Quality Agreements
    • Vendor auditing system (frequency, depth, obstacles to overcome)
  • FDA Inspection Considerations
    • Types of inspections – GMP vs. PAI vs. Pre-License (BLA)
    • Readiness steps to consider
DAY 02(11:00 AM - 5:00 PM EDT)
  • Phase Appropriate GMP Compliance
    • Legal basis
    • Applicability to placebos
  • FDA Guideline for Phase 1 GMP Compliance
  • FDA Guideline for Phase 2 and 3 GMP Compliance (legacy 1992 guideline no longer applicable to Phase 1)
  • EU Annex 13 – Investigational Medicinal Products
  • Importance of Data Integrity
  • GMP data versus “application data” and importance to PAI/PLI Success
  • Practical application of GMP principles to investigational drug manufacturing
    • Facility considerations – size, scale
    • Equipment qualification
    • Process and analytical method validation issues
    • Scale-up issues
    • Sterility and environmental control
    • Stability issues
    • Procedures – level of detail
    • Master and batch production and control records
    • Change control – at what point does this apply?
    • Deviation investigation
    • Batch disposition and role of the Quality Unit at the CMO vs the Virtual Company
  • Final discussion, Q&A
Seminar (Price/Register)
May 10 - May 11 , 2021

Single Registration


Group-Max. 10 Attendees


Seminar Fee Includes:
Lunch
AM-PM Tea/Coffee
Seminar Material
Attendance Certificate
$100 Gift Cert for next seminar

Other Registration Option
  1. Download the Order Form
  2. Fill this form with attendee details & payment details
  3. Fax your PO to 1-888-883-7697 or,
  4. Email it to cs@compliance.world

Payment Mode

By Check -

Pay your check issued from the payee to "Redstone Learning Inc." (Our Parent Company) and mail the check to –
Compliance.world (Redstone Learning Inc.)
1180 Avenue of the Americas,
8th Floor, New York,
NY 10036

  Media Partners

If you wish to partner with us for this event

please contact us: partner or
call us: 1-866-978-0800

Media Partner Benefits

  • Logo and company data on the event website.
  • Logo on the conference material distributed during the conference.
  • Media Partner’s brochure distributed along with conference material.
  • Logo on all the mailings before and after the event.
  • 10% discount to media partner's subscribers.

Media Partner to do

  • Banner (min 728x90 or 468x60) on the Media Partner website.
  • Insertion of the event in the event calendar, both printed and/or online.
  • Announcement article of the conference on the Magazine and/or Website.
  • Dedicated email blast to all subscribers of Media Partner.
  • Article on the Magazine and/or Website after the conference.

  Sponsors

If you wish to partner with us for this event

please contact us: sponsor@compliance.world or
call us: 1-866-978-0800
Speaker: David L Chesney, Principal and General Manager, DL Chesney Consulting, L

David L. Chesney is the Principal and General Manager of DL Chesney Consulting, LLC.

His career includes 23 years with the FDA and over 21 years in GMP and GCP consulting worldwide. In his consulting practice, Mr. Chesney helps clients prevent quality and compliance problems through proactive assessment and planning, and when necessary, with remediation planning and health regulatory authority communications.

Until recently, he served as Vice President, Strategic Compliance Services for PAREXEL Consulting, a business unit of PAREXEL International LLC. Prior to joining PAREXEL Consulting in 1995, Mr. Chesney served 23 years with the FDA, where he advanced from Investigator to Supervisory Investigator and Director, Investigations Branch, working in the Boston, Seattle and Philadelphia District Offices. In 1991, he was appointed the District Director, FDA San Francisco District Office, where he served until joining PAREXEL in 1995. For 19 years, he led the Strategic Compliance Consulting group, and also personally provided regulatory enforcement related consulting services to the pharmaceutical, medical device and biologics industries, plus technical assistance to legal counsel in FDA regulatory matters. Mr. Chesney has a bachelor's degree and postgraduate credits in biology from California State University, Northridge and San Diego, and received a Certificate in Health Care Compliance from Seton Hall University School of Law.




Get in touch

646 905 0515

Fax

212-751-3500